China Medical System Holdings Limited (CHSYF)

OTCMKTS · Delayed Price · Currency is USD
0.931
0.00 (0.00%)
Mar 11, 2025, 4:00 PM EST
-41.83%
Market Cap 2.62B
Revenue (ttm) 965.23M
Net Income (ttm) 191.32M
Shares Out n/a
EPS (ttm) 0.08
PE Ratio 13.70
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 110
Average Volume 1,841
Open 0.931
Previous Close 0.931
Day's Range 0.931 - 0.931
52-Week Range 0.931 - 1.518
Beta 0.83
RSI 36.95
Earnings Date Mar 14, 2025

About CHSYF

China Medical System Holdings Limited, an investment holding company, manufactures, sells, markets, and promotes pharmaceutical products in the People’s Republic of China. Its products include VALTOCO, a diazepam nasal spray to treat seizure clusters; Plendil for the treatment of hypertension and stable angina pectoris; XinHuoSu to treat acute heart failure; Deanxit for mild-to-moderate depression, anxiety, and psychosomatic affections; METOJECT, a methotrexate injection for recalcitrant disabling psoriasis; and Ursofalk for the treatment of ch... [Read more]

Sector Healthcare
Founded 1995
Employees 5,701
Stock Exchange OTCMKTS
Ticker Symbol CHSYF
Full Company Profile

Financial Performance

In 2023, CHSYF's revenue was 8.01 billion, a decrease of -12.43% compared to the previous year's 9.15 billion. Earnings were 2.40 billion, a decrease of -26.33%.

Financial numbers in CNY Financial Statements

News

There is no news available yet.